(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
@ $7.08
发出时间: 13 Feb 2024 @ 23:17
回报率: -37.15%
上一信号: Feb 7 - 02:53
上一信号:
回报率: 1.29 %
Live Chart Being Loaded With Signals
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy...
Stats | |
---|---|
今日成交量 | 57 153.00 |
平均成交量 | 125 360 |
市值 | 109.71M |
EPS | $0 ( 2024-03-21 ) |
下一个收益日期 | ( $-0.480 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.18 |
ATR14 | $0.0120 (0.27%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-31 | Firestone Gregory A. | Sell | 119 | Common Stock |
2024-03-31 | Koblish Antony | Sell | 385 | Common Stock |
2024-03-31 | Talmo Paul | Sell | 190 | Common Stock |
2024-03-31 | Smeykal Megan | Sell | 96 | Common Stock |
2024-03-31 | Murphy Peter C. | Sell | 163 | Common Stock |
INSIDER POWER |
---|
54.62 |
Last 99 transactions |
Buy: 1 093 142 | Sell: 280 600 |
音量 相关性
TELA Bio Inc 相关性 - 货币/商品
TELA Bio Inc 财务报表
Annual | 2023 |
营收: | $58.45M |
毛利润: | $40.11M (68.62 %) |
EPS: | $-2.04 |
FY | 2023 |
营收: | $58.45M |
毛利润: | $40.11M (68.62 %) |
EPS: | $-2.04 |
FY | 2022 |
营收: | $41.42M |
毛利润: | $27.04M (65.30 %) |
EPS: | $-2.73 |
FY | 2021 |
营收: | $29.46M |
毛利润: | $19.12M (64.88 %) |
EPS: | $-2.57 |
Financial Reports:
No articles found.
TELA Bio Inc
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。